The effect of incretin-based drugs on the riks of acute pancreatitis: a review.

Published in: Journal of diabetes and metabolic disorders (2024)

The majority of studies have shown that DPP4is, GLP1RAs and tirzepatide are effective and safe in most T2DM patients. However, the follow-up time for patients treated with tirzepatide is short, therefore more studies are required to confirm the safety of this drug.

Keyphrases

newly diagnosed
ejection fraction
case control
prognostic factors
emergency department
drug induced
metabolic syndrome
patient reported outcomes
skeletal muscle
insulin resistance